A genetic etiology for interruption of the aortic arch type B

Mark B. Lewin, Elizabeth A. Lindsay, Vesna Jurecic, Veronica Goytia, Jeffrey A. Towbin, Antonio Baldini

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Interrupted aortic arch (IAA) type B is a congenital heart defect believed to be caused by an anomaly of branchial arch mesenchymal development. IAA type B has been associated with DiGeorge syndrome (DGS), which includes conotruncal heart defects, T-cell immunodeficiency, hypocalcemia, and facial abnormalities. The great majority of DGS cases are associated with hemizygous deletions at the chromosome 22q11 locus. The present study was designed to establish the involvement of the 22q11 locus in the etiology of IAA type B, independently from the typical DGS phenotype. An evaluation was performed on 73 patients with conotruncal heart defects using fluorescence in situ hybridization (FISH) analysis with probes from the 22q11 DGS locus. From this group, 7 patients were deleted (including 4 of the 11 patients with IAA type B). FISH analysis was extended to a total of 22 patients with IAA type B and 11 of these (50%) were deleted. FISH and Southern blot analyses using additional markers within the DiGeorge chromosomal region were performed on patients found not to be deleted in the initial FISH screening. No small deletions or rearrangements were detected. In our patient population, a single, specific genetic defect is the basis for one half of the IAA type B cases. These data suggest that IAA type B is one of the most etiologically homogeneous congenital heart defects. A 22q11 deletion in IAA type B may or may not be associated with the typical DGS phenotype. Therefore, IAA type B, per se, should be an indication for 22q11 deletion testing.

Original languageEnglish
Pages (from-to)493-497
Number of pages5
JournalThe American Journal of Cardiology
Volume80
Issue number4
DOIs
Publication statusPublished - Aug 15 1997

Fingerprint

Thoracic Aorta
DiGeorge Syndrome
Fluorescence In Situ Hybridization
Congenital Heart Defects
Branchial Region
Phenotype
Chromosome Deletion
Hypocalcemia
Southern Blotting
T-Lymphocytes
Population

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Lewin, M. B., Lindsay, E. A., Jurecic, V., Goytia, V., Towbin, J. A., & Baldini, A. (1997). A genetic etiology for interruption of the aortic arch type B. The American Journal of Cardiology, 80(4), 493-497. https://doi.org/10.1016/S0002-9149(97)00401-3

A genetic etiology for interruption of the aortic arch type B. / Lewin, Mark B.; Lindsay, Elizabeth A.; Jurecic, Vesna; Goytia, Veronica; Towbin, Jeffrey A.; Baldini, Antonio.

In: The American Journal of Cardiology, Vol. 80, No. 4, 15.08.1997, p. 493-497.

Research output: Contribution to journalArticle

Lewin, MB, Lindsay, EA, Jurecic, V, Goytia, V, Towbin, JA & Baldini, A 1997, 'A genetic etiology for interruption of the aortic arch type B', The American Journal of Cardiology, vol. 80, no. 4, pp. 493-497. https://doi.org/10.1016/S0002-9149(97)00401-3
Lewin MB, Lindsay EA, Jurecic V, Goytia V, Towbin JA, Baldini A. A genetic etiology for interruption of the aortic arch type B. The American Journal of Cardiology. 1997 Aug 15;80(4):493-497. https://doi.org/10.1016/S0002-9149(97)00401-3
Lewin, Mark B. ; Lindsay, Elizabeth A. ; Jurecic, Vesna ; Goytia, Veronica ; Towbin, Jeffrey A. ; Baldini, Antonio. / A genetic etiology for interruption of the aortic arch type B. In: The American Journal of Cardiology. 1997 ; Vol. 80, No. 4. pp. 493-497.
@article{cf9485ac5c244551ba3c9456cd634d98,
title = "A genetic etiology for interruption of the aortic arch type B",
abstract = "Interrupted aortic arch (IAA) type B is a congenital heart defect believed to be caused by an anomaly of branchial arch mesenchymal development. IAA type B has been associated with DiGeorge syndrome (DGS), which includes conotruncal heart defects, T-cell immunodeficiency, hypocalcemia, and facial abnormalities. The great majority of DGS cases are associated with hemizygous deletions at the chromosome 22q11 locus. The present study was designed to establish the involvement of the 22q11 locus in the etiology of IAA type B, independently from the typical DGS phenotype. An evaluation was performed on 73 patients with conotruncal heart defects using fluorescence in situ hybridization (FISH) analysis with probes from the 22q11 DGS locus. From this group, 7 patients were deleted (including 4 of the 11 patients with IAA type B). FISH analysis was extended to a total of 22 patients with IAA type B and 11 of these (50{\%}) were deleted. FISH and Southern blot analyses using additional markers within the DiGeorge chromosomal region were performed on patients found not to be deleted in the initial FISH screening. No small deletions or rearrangements were detected. In our patient population, a single, specific genetic defect is the basis for one half of the IAA type B cases. These data suggest that IAA type B is one of the most etiologically homogeneous congenital heart defects. A 22q11 deletion in IAA type B may or may not be associated with the typical DGS phenotype. Therefore, IAA type B, per se, should be an indication for 22q11 deletion testing.",
author = "Lewin, {Mark B.} and Lindsay, {Elizabeth A.} and Vesna Jurecic and Veronica Goytia and Towbin, {Jeffrey A.} and Antonio Baldini",
year = "1997",
month = "8",
day = "15",
doi = "10.1016/S0002-9149(97)00401-3",
language = "English",
volume = "80",
pages = "493--497",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - A genetic etiology for interruption of the aortic arch type B

AU - Lewin, Mark B.

AU - Lindsay, Elizabeth A.

AU - Jurecic, Vesna

AU - Goytia, Veronica

AU - Towbin, Jeffrey A.

AU - Baldini, Antonio

PY - 1997/8/15

Y1 - 1997/8/15

N2 - Interrupted aortic arch (IAA) type B is a congenital heart defect believed to be caused by an anomaly of branchial arch mesenchymal development. IAA type B has been associated with DiGeorge syndrome (DGS), which includes conotruncal heart defects, T-cell immunodeficiency, hypocalcemia, and facial abnormalities. The great majority of DGS cases are associated with hemizygous deletions at the chromosome 22q11 locus. The present study was designed to establish the involvement of the 22q11 locus in the etiology of IAA type B, independently from the typical DGS phenotype. An evaluation was performed on 73 patients with conotruncal heart defects using fluorescence in situ hybridization (FISH) analysis with probes from the 22q11 DGS locus. From this group, 7 patients were deleted (including 4 of the 11 patients with IAA type B). FISH analysis was extended to a total of 22 patients with IAA type B and 11 of these (50%) were deleted. FISH and Southern blot analyses using additional markers within the DiGeorge chromosomal region were performed on patients found not to be deleted in the initial FISH screening. No small deletions or rearrangements were detected. In our patient population, a single, specific genetic defect is the basis for one half of the IAA type B cases. These data suggest that IAA type B is one of the most etiologically homogeneous congenital heart defects. A 22q11 deletion in IAA type B may or may not be associated with the typical DGS phenotype. Therefore, IAA type B, per se, should be an indication for 22q11 deletion testing.

AB - Interrupted aortic arch (IAA) type B is a congenital heart defect believed to be caused by an anomaly of branchial arch mesenchymal development. IAA type B has been associated with DiGeorge syndrome (DGS), which includes conotruncal heart defects, T-cell immunodeficiency, hypocalcemia, and facial abnormalities. The great majority of DGS cases are associated with hemizygous deletions at the chromosome 22q11 locus. The present study was designed to establish the involvement of the 22q11 locus in the etiology of IAA type B, independently from the typical DGS phenotype. An evaluation was performed on 73 patients with conotruncal heart defects using fluorescence in situ hybridization (FISH) analysis with probes from the 22q11 DGS locus. From this group, 7 patients were deleted (including 4 of the 11 patients with IAA type B). FISH analysis was extended to a total of 22 patients with IAA type B and 11 of these (50%) were deleted. FISH and Southern blot analyses using additional markers within the DiGeorge chromosomal region were performed on patients found not to be deleted in the initial FISH screening. No small deletions or rearrangements were detected. In our patient population, a single, specific genetic defect is the basis for one half of the IAA type B cases. These data suggest that IAA type B is one of the most etiologically homogeneous congenital heart defects. A 22q11 deletion in IAA type B may or may not be associated with the typical DGS phenotype. Therefore, IAA type B, per se, should be an indication for 22q11 deletion testing.

UR - http://www.scopus.com/inward/record.url?scp=0030768896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030768896&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(97)00401-3

DO - 10.1016/S0002-9149(97)00401-3

M3 - Article

VL - 80

SP - 493

EP - 497

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 4

ER -